Provided by Tiger Trade Technology Pte. Ltd.

BioNTech SE

108.71
+2.091.96%
Volume:352.97K
Turnover:38.42M
Market Cap:28.16B
PE:-38.86
High:110.28
Open:106.86
Low:106.86
Close:106.62
52wk High:124.49
52wk Low:81.20
Shares:259.03M
Float Shares:104.00M
Volume Ratio:0.71
T/O Rate:0.34%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.7976
EPS(LYR):-2.8652
ROE:-3.04%
ROA:-2.30%
PB:1.28
PE(LYR):-37.94

Loading ...

Schaeffler India Announces Resignation of Non-Executive Director Andreas Schick

TIPRANKS
·
Feb 07

Pfizer and BioNTech Pause modRNA Shingles Ambitions

TIPRANKS
·
Feb 05

Jiangsu Sinopep-Allsino Biopharmaceutical Gets Good Manufacturing Practice Certificate for COVID-19 Drug Raw Material

MT Newswires Live
·
Feb 04

BioNTech Shares Lower After Leerink Partners Downgrade

MT Newswires Live
·
Feb 03

European Equities Traded in the US as American Depositary Receipts Rise in Monday Trading

MT Newswires Live
·
Feb 03

BioNTech SE (BNTX) Gets a Buy from Morgan Stanley

TIPRANKS
·
Feb 02

Assessing BioNTech (BNTX) Valuation After Goldman Sachs Buy Upgrade And Oncology Growth Focus

Simply Wall St.
·
Feb 02

Leerink Partners Downgrades BioNTech to Market Perform From Outperform, Adjusts Price Target to $113 From $112

MT Newswires Live
·
Feb 02

Commerzbank (0RLW) Gets a Hold from Warburg Research

TIPRANKS
·
Feb 02

BioNTech Se : Leerink Partners Cuts to Market Perform From Outperform; Raises Target Price to $113.00 From $112.00

THOMSON REUTERS
·
Feb 02

BioNTech and Bristol-Myers Squibb Advance Pumitamig Trial in Aggressive Brain Cancer

TIPRANKS
·
Jan 31

Andreas de Wit Bought 11% More Shares In De.mem

Simply Wall St.
·
Jan 30

De.mem Director Increases Shareholding Through Core Chemicals Funding Placement

TIPRANKS
·
Jan 29

BioNTech Appoints Kylie Jimenez as Chief People Officer

Reuters
·
Jan 28

BioNTech’s New Phase III Prostate Cancer Trial Adds Long-Term Upside Potential for BNTX

TIPRANKS
·
Jan 27

Invivyd Advances Phase 3 VYD2311 COVID-19 Prevention Trial, Keeping Optionality Alive for Investors

TIPRANKS
·
Jan 27

Pfizer and BioNTech Move Closer to a Single-Shot Flu–COVID Vaccine: What Investors Should Watch

TIPRANKS
·
Jan 27

Traws Pharma Completes Enrollment of Ratutrelvir Clinical Study in PAXLOVID®-Eligible and Ineligible COVID-19 Patients; Announces Plans for Added Indication for Tivoxavir Marboxil as a Prophylactic Treatment for Seasonal Influenza

GlobeNewswire
·
Jan 26

Bristol-Myers Squibb and BioNTech Advance New Phase 3 Lung Cancer Trial With Pumitamig

TIPRANKS
·
Jan 24

US Officially Exits WHO, Citing COVID-19 Failures, Political Misalignment

Benzinga_recent_news
·
Jan 23